Search

Background: Described for the first time in 2003, the robotic pancreatic surgery shows interesting results. The evaluation of post-operative outcomes is necessary once we describe an innovative surgical approach., Methods: We have performed a retrospective analysis of a prospectively maintained database on robotic pancreatic surgery including malignant and benign indications for surgery., Results: A total of 50 consecutive patients underwent robotic pancreatic surgery (26 pancreatico duodenectomy and 24 distal pancreatectomy) between January 2012 and July 2015 in a single centre. The overall operative time was 425 (390-620) min. In a subgroup of highly selected malignant tumours, we were able to achieve 88% of R0 resection with robotic approach. A number of lymphnodes rose significantly with growing experience (p = .025). The overall major complication rate (15%), as well as pancreatic fistula rate (16%) were acceptable. The two-year overall survival for the whole group was 65%., Conclusion: The robotic pancreatic surgery in a highly selected group of patients seems safe and feasible. The cost-effectiveness and long-term oncologic outcomes need further investigations.

Infusion of 1000 ml of 6% hydroxyethylstarch (HES) of the third generation 130/0.42 or crystalloid solutions was conducted to patients before performance of operation on abdominal cavity organs using epidural anesthesia. While HES application the average arterial pressure after induction into anesthesia was less pronounced and concentration of C-reactive protein on the third postoperative day was lesser. It is concluded, that HES 130/0.42 secures the hemodynamic indices stability and reduction of systemic inflammatory reaction severity in the patients and do not influence hemostasis and renal function.

The analysis of the clinical and cost efficiency on application of unilateral spinal anesthesia in urology by hyperbaric bupivacaine solution is carried out. It is shown the possibility of usage presented method on kidney and upper third of ureter surgery and considerably reduces the anesthesia costs as compared to endotracheal anesthesia.

The device enables to examine about 40 000--60 000 cells per min. The results are presented by the distribution curves of the ultraviolet fluorescence intensity.